Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour

Journal of Cellular and Molecular Medicine

Volumn 22, Issue 5, 2018, Pages 2760-2773

  Fallen, Shannon ^a   Baxter, David ^a   Wu, Xiaogang ^a   Kim, Taek Kyun ^a   Shynlova, Oksana ^b,c   Lee, Min Young ^a   Scherler, Kelsey ^a   Lye, Stephen ^b,c   Hood, Leroy ^a   Wang, Kai ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

exosome; extracellular vesicle; microRNA; next generation sequencing; preterm birth; preterm labour

Indexed keywords

ANTEPARTUM HEMORRHAGE; ARTICLE; ELECTRON MICROSCOPY; FEMALE; HUMAN; NEXT GENERATION SEQUENCING; PLACENTA DISORDER; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SIZE EXCLUSION CHROMATOGRAPHY; BLOOD; EXOSOME; GENE REGULATORY NETWORK; GENETICS; HUMAN CHROMOSOME; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; REPRODUCIBILITY; SEQUENCE ANALYSIS;

BIOLOGICAL MARKER; MICRORNA; RNA;

BIOMARKERS; CHROMOSOMES, HUMAN; EXTRACELLULAR VESICLES; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; OBSTETRIC LABOR, PREMATURE; PLACENTA; PREGNANCY; REPRODUCIBILITY OF RESULTS; RNA; SEQUENCE ANALYSIS, RNA;

EID: 85043358936     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.13570     Document Type: Article

References (64)

1. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88:31-38.
2. Morken N-H. Preterm birth: new data on a global health priority. The Lancet. 2012;379:2128-2130.
3. Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909-916.
4. Taketa K. α-fetoprotein: reevaluation in hepatology. Hepatology. 1990;12:1420-1432.
5. Verma P, Pandey RK, Prajapati P, Prajapati VK. Circulating MicroRNAs: potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases. Front Microbiol. 2016;7:1274.
6. Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res-Fund Mol M. 2011;717:1-8.
7. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003-5008.
8. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins. Nat Cell Biol. 2011;13:423-433.
9. Siriwardena AK, Mason JM, Mullamitha S, et al. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol. 2014;11:446-459.
10. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA. 2009;106:4402-4407.
11. Akat KM, Moore-McGriff DV, Morozov P, et al. Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA. 2014;111:11151-11156.
12. Devaux Y, Vausort M, Goretti E, et al. Use of circulating MicroRNAs to diagnose acute myocardial infarction. Clin Chem. 2012;58:559.
13. Tetta C, Ghigo E, Silengo L, et al. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine. 2013;44:11-19.
14. Pereira L, Reddy AP, Alexander AL, et al. Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol. 2010;202:555.
15. Georgiou HM, Di Quinzio MKW, Permezel M, Brennecke SP. Predicting preterm labour: current status and future prospects. Dis Markers. 2015;2015:435014.
16. Myntti T, Rahkonen L, Nupponen I, et al. Amniotic fluid infection in preterm pregnancies with intact membranes. Dis Markers. 2017;2017:8167276.
17. Weichert A, von Schöning D, Fischer T, Thomas A. Cervical sonoelastography and cervical length measurement but not cervicovaginal interleukin-6 are predictors for preterm birth. Ultrasound Int Open. 2016;2:E83-E89.
18. Dulay AT, Buhimschi IA, Zhao G, et al. Compartmentalization of acute phase reactants interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine. 2015;76:236-243.
19. Shahshahan Z, Rasouli O. The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women. Adv Biomed Res. 2014;3:154.
20. Mouillet J-F, Ouyang Y, Coyne C, Sadovsky Y. MicroRNAs in placental health and disease. Am J Obstet Gynecol. 2015;213:S163-S172.
21. Hromadnikova I, Kotlabova K, Ondrackova M, et al. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications. DNA Cell Biol. 2015;34:437-457.
22. Hromadnikova I, Kotlabova K, Ondrackova M, et al. Circulating C19MC MicroRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm. 2013;2013:186041.
23. Elovitz MA, Anton L, Bastek J, Brown AG. Can microRNA profiling in maternal blood identify women at risk for preterm birth? Am J Obstet Gynecol. 2015;212(782):e1-e5.
24. Gray C, McCowan LM, Patel R, et al. Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study. Sci Rep. 2017;7:815.
25. Tian G, Yin X, Luo H, et al. Sequencing bias: comparison of different protocols of MicroRNA library construction. BMC Biotechnol. 2010;10:64.
26. Toedling J, Servant N, Ciaudo C, et al. Deep-sequencing protocols influence the results obtained in Small-RNA sequencing. PLoS One. 2012;7:e32724.
27. Mol EA, Goumans M-J, Doevendans PA, et al. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomed Nanotechnol Biol Med. 2017;13:2061-2065.
28. Blans K, Hansen MS, Sørensen LV, et al. Pellet-free isolation of human and bovine milk extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2017;6:1294340.
29. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3: Unit 3.22.
30. Edgar R, Domrachev M, Lash A. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucl Acids Res. 2002;30:207-210.
31. Chou CH, Chang NW, Shrestha S, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2016;44:D239-D247.
32. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.
33. Uhlen M, Bjorling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920-1932.
34. Chatr-Aryamontri A, Oughtred R, Boucher L, et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res. 2017;45:D369-D379.
35. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human Protein Reference Database–2009 update. Nucleic Acids Res. 2009;37:D767-D772.
36. Bader GD, Betel D, Hogue CW. BIND: the biomolecular interaction network database. Nucleic Acids Res. 2003;31:248-250.
37. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.
38. Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353-D361.
39. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-2504.
40. Seitz H, Royo H, Bortolin M-L, et al. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004;14:1741-1748.
41. Gardiner E, Beveridge NJ, Wu JQ, et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry. 2012;17:827-840.
42. Ahmed MS, Aleksunes LM, Boeuf P, et al. IFPA Meeting 2012 Workshop Report II: epigenetics and imprinting in the placenta, growth factors and villous trophoblast differentiation, role of the placenta in regulating fetal exposure to xenobiotics during pregnancy, infection and the placenta. Placenta. 2013;34:S6-S10.
43. Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, et al. Pregnancy-associated miRNA-clusters. J Reprod Immunol. 2013;97:51-61.
44. Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Meth. 2014;11:809-815.
45. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci. 2011;18:46-56.
46. Zhu XM, Han T, Sargent IL, et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009;200:e1-e7.
47. Lee I, Baxter D, Lee MY, et al. The importance of standardization on analyzing circulating RNA. Mol Diagn Ther. 2017;21:259-268.
48. Wu X, Kim T-K, Baxter D, et al. sRNAnalyzer—a flexible and customizable small RNA sequencing data analysis pipeline. Nucleic Acids Res. 2017;45:12140-12151.
49. Kosaka N, Iguchi H, Hagiwara K, et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 2013;288:10849-10859.
50. Frank F, Sonenberg N, Nagar B. Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2. Nature. 2010;465:818-822.
51. Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014;8:1649-1658.
52. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.
53. Takacs P, Jaramillo S, Datar R, et al. Placental mRNA in maternal plasma as a predictor of ectopic pregnancy. Int J Gynaecol Obstet. 2012;117:131-133.
54. Purwosunu Y, Sekizawa A, Farina A, et al. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn. 2007;27:772-777.
55. Sekizawa A, Purwosunu Y, Farina A, et al. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation. BJOG. 2010;117:557-564.
56. Lewis A, Mitsuya K, Umlauf D, et al. Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet. 2004;36:1291-1295.
57. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genom. 2007;8:166.
58. Kotlabova K, Doucha J, Hromadnikova I. Placental-specific microRNA in maternal circulation–identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol. 2011;89:185-191.
59. Zhao Z, Zhao Q, Warrick J, et al. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem. 2012;58:896-905.
60. Miura K, Hasegawa Y, Abe S, et al. Clinical applications of analysis of plasma circulating complete hydatidiform mole pregnancy-associated miRNAs in gestational trophoblastic neoplasia: a preliminary investigation. Placenta. 2014;35:787-789.
61. Hasegawa Y, Miura K, Furuya K, et al. Identification of complete hydatidiform mole pregnancy-associated microRNAs in plasma. Clin Chem. 2013;59:1410-1412.
62. Hromadnikova I, Kotlabova K, Doucha J, et al. Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications. J Mol Diagn. 2012;14:160-167.
63. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106:4402-4407.
64. Montenegro D, Romero R, Kim SS, et al. Expression patterns of microRNAs in the chorioamniotic membranes: a role for microRNAs in human pregnancy and parturition. J Pathol. 2009;217:113-121.